Physician profile
Lisa Ma
NPI 1942654132
$523.61
in general payments reported to CMS, 2019-2025
11 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.43 · 2022: $124 · 2023: $65.92 · 2024: $159 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $175.64 | 2022-2025 | Caldolor |
| Takeda Pharmaceuticals U.S.A., INC. | $70.26 | 2024-2025 | Entyvio |
| Merck Sharp & Dohme LLC | $35.66 | 2023 | Bridion |
| Phathom Pharmaceuticals, INC. | $32.82 | 2024 | Voquezna |
| Pacira Pharmaceuticals Incorporated | $32.47 | 2024-2025 | Exparel, Iovera |
| Chiesi USA, INC. | $29.56 | 2022 | |
| Heron Therapeutics, INC. | $24.58 | 2022 | |
| Qol Medical, LLC | $22.40 | 2025 | Sucraid |
| Abbvie INC. | $18.85 | 2025 | |
| Lilly USA, LLC | $16.94 | 2024 | Omvoh |
| Vertex Pharmaceuticals Incorporated | $14.95 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Ma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.